Dane L. Shiltz

Dane L. Shiltz

Ferris State University

H-index: 6

North America-United States

About Dane L. Shiltz

Dane L. Shiltz, With an exceptional h-index of 6 and a recent h-index of 5 (since 2020), a distinguished researcher at Ferris State University, specializes in the field of Game-based learning, interprofessional education, internal medicine clinical practice.

His recent articles reflect a diverse array of research interests and contributions to the field:

Impact of an inpatient pharmacist-driven renal dosing policy on order verification time and patient safety

The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States

1317: FEIBA® Reversal for Apixaban and Rivaroxaban in Intracranial and Nonintracranial Hemorrhage

Factor VIII inhibitor bypassing activity (FEIBA) reversal for apixaban and rivaroxaban in patients with acute intracranial and nonintracranial hemorrhage

PBI9 The TOTAL Medical Expenditure and out-of-Pocket Expenditure of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients in the United States

FEIBA® Reversal for Apixaban and Rivaroxaban in Patients with Intracranial and Non-intracranial Hemorrhages

Dane L. Shiltz Information

University

Position

Associate Professor of Pharmacy Practice

Citations(all)

144

Citations(since 2020)

91

Cited By

97

hIndex(all)

6

hIndex(since 2020)

5

i10Index(all)

4

i10Index(since 2020)

3

Email

University Profile Page

Ferris State University

Google Scholar

View Google Scholar Profile

Dane L. Shiltz Skills & Research Interests

Game-based learning

interprofessional education

internal medicine clinical practice

Top articles of Dane L. Shiltz

Title

Journal

Author(s)

Publication Date

Impact of an inpatient pharmacist-driven renal dosing policy on order verification time and patient safety

SAGE Open Medicine

Kayla Berry

Laura Postlmayr

Dane Shiltz

Jessi Parker

Calvin Ice

2024/2

The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States

Expert Review of Pharmacoeconomics & Outcomes Research

Q Ding

D Shiltz

D Hossami

A Konieczny

2022/8

1317: FEIBA® Reversal for Apixaban and Rivaroxaban in Intracranial and Nonintracranial Hemorrhage

Critical Care Medicine

Aleah Hunt

Shawn Coffeen

Dane Shiltz

Calvin Ice

Jessica Parker

2021/1/1

Factor VIII inhibitor bypassing activity (FEIBA) reversal for apixaban and rivaroxaban in patients with acute intracranial and nonintracranial hemorrhage

Annals of Pharmacotherapy

Aleah R Hunt

Shawn N Coffeen

Dane L Shiltz

Calvin Ice

Jessi Parker

2021/12

PBI9 The TOTAL Medical Expenditure and out-of-Pocket Expenditure of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients in the United States

Value in Health

Q Ding

D Shiltz

D Hossami

2021/6/1

FEIBA® Reversal for Apixaban and Rivaroxaban in Patients with Intracranial and Non-intracranial Hemorrhages

medRxiv

Aleah R Hunt

Shawn N Coffeen

Dane L Shiltz

Calvin Ice

Jessica Parker

2020/8/25

See List of Professors in Dane L. Shiltz University(Ferris State University)